Literature DB >> 12220553

The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).

Amy M Beebe1, Daniel J Cua, Rene de Waal Malefyt.   

Abstract

Interleukin-10 (IL-10) is an immunoregulatory cytokine that plays a crucial role in inflammatory and immune reactions. It has potent anti-inflammatory and immunosuppressive activities on myeloid cell functions which forms a solid basis for its use in acute and chronic inflammatory diseases. Here, we discuss the role of IL-10 in autoimmune diseases and examine its beneficial effects in cellular-based autoimmune diseases such as multiple sclerosis (MS) or its involvement in humoral-based autoimmune diseases such as systemic lupus erythematosus (SLE). Inhibition of the immune stimulatory activities of IL-10 may provide novel approaches in the treatment of humoral autoimmune diseases, infectious diseases and cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220553     DOI: 10.1016/s1359-6101(02)00025-4

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  52 in total

1.  Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis.

Authors:  Wen-jia Peng; Bing-xiang Wang; Hai-feng Pan; Jin-hui Tao; Jun-qing Zhang; Qian He; Chang-chun Xiao; Jing Wang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 2.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

3.  Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus.

Authors:  Adriana Elizabeth Monsiváis-Urenda; Lourdes Baranda; Crisol Alvarez-Quiroga; Carlos Abud-Mendoza; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2010-12-29       Impact factor: 8.317

4.  Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients.

Authors:  Hai-Ling Qiao; Qiang Wen; Na Gao; Xin Tian; Lin-Jing Jia
Journal:  Eur J Clin Pharmacol       Date:  2007-01-16       Impact factor: 2.953

Review 5.  Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

6.  Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients.

Authors:  Zhao Ming Tang; Min Fang; Jin Ping Wang; Peng Cheng Cai; Ping Wang; Li Hua Hu
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

7.  Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves' disease.

Authors:  Omid Khalilzadeh; Mehdi Anvari; Fatemeh Momen-Heravi; Alireza Esteghamati; Armin Rashidi; Mahdi Mahmoudi; Behrouz Nikbin; Aliakbar Amirzargar
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

8.  Extended IL10 haplotypes and their association with HIV progression to AIDS.

Authors:  T K Oleksyk; S Shrestha; A L Truelove; J J Goedert; S M Donfield; J Phair; S Mehta; S J O'Brien; M W Smith
Journal:  Genes Immun       Date:  2009-03-19       Impact factor: 2.676

9.  BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

Authors:  Danielle T Avery; Susan L Kalled; Julia I Ellyard; Christine Ambrose; Sarah A Bixler; Marilyn Thien; Robert Brink; Fabienne Mackay; Philip D Hodgkin; Stuart G Tangye
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 10.  Cytokine networks in systemic lupus erythematosus.

Authors:  Hooi-Ming Lee; Hidehiko Sugino; Norihiro Nishimoto
Journal:  J Biomed Biotechnol       Date:  2010-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.